Arora Puneet S. 4
4 · Skye Bioscience, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Arora Puneet S.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-03+225,000→ 225,000 totalExercise: $5.89Exp: 2034-09-03→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on the one year anniversary of the grant date and 1/48th monthly thereafter.